Merck and Co. is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug Keytruda, the best-selling medicine in the world.

Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

The company recently completed a massive expansion in Durham and is acquiring a Raleigh company for billions. Join us as we honor outstanding C-Level Executives for their invaluable contributions to ...

Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease in more than a decade.

Top Stories Pentagon ending contracts Winning $389K win vanishes Delta passengers stranded La Niña is dead Diet and lung cancer risk ChatGPT AI action figure trend ...

Also, Merck’s Durham office has 10 active Employee Business Resource Groups, which are voluntary efforts led by employees who “aim to foster a diverse, inclusive work environment through ...

Merck sign outside its plant in Durham (WRAL photo) by Jamie Crockett, NC A&T via N.C. Biotech Center — June 12, 2023 .

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital investment since 2018 focused on expanding domestic manufacturing and ...

DURHAM -- Merck & Co. Inc. said yesterday that it plans to spend about $300 million on a second expansion of its vaccine-manufacturing plant in Durham. The expansion will include up to 180 new jobs.

DURHAM – North Carolina’s unemployment rate is still hovering near 10 percent, but don’t tell that to pharmaceutical giant Merck & Co. By the end of this year, Merck will grow its Durham ...